Not yet recruiting NCT07280117
Magnesium-based Bioresorbable Pins for Membrane Fixation
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Sinus Floor Augmentation. Basic parameters: from 21 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Magnesium-based Bioresorbable Pins for Membrane Fixation in Case of Sinus Floor Elevation (SFE): a Prospective Case Series
Overview
The goal of this research project is to assess the clinical performance and degradation of bioresorbable Mg- based pins for membrane fixation in patients with sinus floor elevation.
Primary outcome measures
- Visually successful fixation of the membrane: [Time frame: During SFE]
Secondary outcome measures (1)
- Material degradation of the Mg pins [Time frame: after 6 months]
Eligibility criteria
Inclusion criteria
- Healthy patients in the aged > 21 years.
- fully or partially edentulous with unilaterally or bilaterally missing upper premolars or molars and an insufficient residual bone height to guarantee primary stability of implants; and requiring a staged approach of SFE and implant surgery
- Subject has been informed and signed the informed consent
Exclusion criteria
- Smoking more than 9 cigarettes per day
- Irradiation in the maxilla-facial region,
- A known metabolic skeletal disease (such as osteomalacia, osteoporosis or osteogenesis imperfecta) or medications that can affect the bone structure
- Allergies / intolerances to the materials
- Known malignancy
- Epilepsy or anamnestic evidence of recurrent falls
- Pregnancy (as contraindicated for CBCT imaging that is routinely performed)
- Manifest hepato-renal disease
- Inability or unwillingness to give informed consent.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Case-only
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07280117 · 2025-01789